Diligence memo · auto-generated · as of July 2, 2026
Centaur Diagnostics, Inc.
Centaur Diagnostics, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Centaur Diagnostics, Inc. operates in Medical Devices, based in BOSTON.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Centaur Diagnostics, Inc. has raised $16M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $16M on 2021-07-30.
Most recent recorded round closed around 2021-07-30.
Valuation (modeled)modeled
Provath models Centaur Diagnostics, Inc. at approximately $291M (range $36M–$912M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.71× the median modeled value of Series B Medical Devices companies in 2019–2021 (10 peers) — value vs value, same stage and era. Within the normal band (71% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 4.9 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 86% of Medical Devices peers (233 compared).
Modeled value ranks above 95% of those peers.
Closest niche peers: Envision Diagnostics, Inc., Onkos Surgical, Inc., Regent Surgical Health Topco, L.P., Specific Diagnostics, Inc., Covenant Surgical Holdings L.P..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.